Subtype
Bone Neoplasm
CI-CAN-00000569Explore in graph →
Non-malignant65 active trials4 approved drugs16 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000569Explore in graph →
Clinical trials
342 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03301857 | Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 | completed | Phase 4 | 85 | AmgenINDUSTRY | 8 | May 20, 2024 | clinicaltrials |
| NCT00211211 | FREE Study - Fracture Reduction Evaluation | completed | Phase 4 | 300 | Medtronic Spine LLCINDUSTRY | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00434447 |
| Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases |
| completed |
| Phase 4 |
| 73 |
| Novartis PharmaceuticalsINDUSTRY |
| 1 |
| Feb 27, 2017 |
| clinicaltrials |
| NCT01304121 | Bioactive Glass Granules in Filling of Bone Defects | completed | Phase 4 | 48 | Turku University HospitalOTHER_GOV | 1 | Jun 16, 2011 | clinicaltrials |
Data updated 23 days agoSource updated May 20, 2024source: clinicaltrials